HK2 and ovarian carcinoma: In terms of mRNAs, one study based on Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases demonstrates the positive correlations between ovarian cancer biomarkers (such as CD44) and glycolytic biomarkers (such as hexokinase 2 (HK2), lactate dehydrogenase A (LDHA), and ENO1) [42].